Treatment responses to integrase strand-transfer inhibitor-containing antiretroviral regimens in combination with short-course rifapentine-based regimens for latent tuberculosis infection among people with HIV.

Kuan-Yin LinHsin-Yun SunChia-Jui YangPo-Liang LuYuan-Ti LeeNan-Yao LeeBo-Huang LiouHung-Jen TangMei-Hui LeeNing-Chi WangTun-Chieh ChenIng-Moi HiiSung-Hsi HuangChi-Ying LinChin-Shiang TsaiChien-Yu ChengChien-Ching Hungnull null

Published in: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America (2023)

Combinations of short-course rifapentine-based regimens and InSTI-containing ART maintained viral suppression for most PWH within 12 months of LTBI treatment completion with low rates of grade 3 or higher adverse events.

Keyphrases

hiv infected
hiv aids
antiretroviral therapy
human immunodeficiency virus
hiv positive
hepatitis c virus
emergency department
hiv testing
south africa
drug induced